Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats

被引:13
作者
Burke, Dennis A. [1 ]
Heshmati, Pooneh [2 ]
Kholdebarin, Ehsan [1 ]
Levin, Edward D. [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
[2] Inst Cognit Sci Studies, Tehran, Iran
关键词
Nicotinic; Antagonist; Learning; alpha; 4; beta; 2; 7; Dizocilpine; CHOLINERGIC CHANNEL ACTIVATOR; LOW-DOSE MECAMYLAMINE; ARM MAZE PERFORMANCE; ACETYLCHOLINE-RECEPTOR; SAZETIDINE-A; PARTIAL AGONIST; REPEATED-ACQUISITION; DESENSITIZING AGENT; HIPPOCAMPAL ALPHA-7; MEMORY PERFORMANCE;
D O I
10.1016/j.ejphar.2014.07.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinic systems have been shown by a variety of studies to be involved in cognitive function. Nicotinic receptors have an inherent property to become desensitized after activation. The relative role of nicotinic receptor activation vs net receptor inactivation by desensitization in the cognitive effects of nicotinic drugs remains to be fully understood. In these studies, we tested the effects of the alpha 7 nicotinic receptor antagonist methyllycaconitine (MLA), the alpha 4 beta 2 nicotinic receptor antagonist dihydro-beta-erythroidine (DH beta E), the nonspecific nicotinic channel blocker mecamylamine and the alpha 4 beta 2 nicotinic receptor desensitizing agent sazetidine-A on teaming in a repeated acquisition test. Adult female Sprague-Dawley rats were trained on a repeated acquisition learning procedure in an 8-arm radial maze. MLA (1-4 mg/kg), DH beta E (1-4 mg/kg), mecamylamine (0.125-0.5 mg/kg) or sazeticline-A (1 and 3 mg/kg) were administered in four different studies either alone or together with the NMDA glutamate antagonist dizocilpine (0.05 and 0.10 mg/kg). MLA significantly counteracted the learning impairment caused by dizocilpine. The overall choice accuracy impairment caused by dizocilpine was significantly attenuated by co-administration of DH beta E. Low doses of the non-specific nicotinic antagonist mecamylamine also reduced dizocilpine-induced repeated acquisition impairment. Sazeticline-A reversed the accuracy impairment caused by dizocilpine. These studies provide evidence that a net decrease in nicotinic receptor activity can improve learning by attenuating learning impairment induced by NMDA glutamate blockade. This adds to evidence in cognitive tests that nicotinic antagonists can improve cognitive function. Further research characterizing the efficacy and mechanisms underlying nicotinic antagonist and desensitization induced cognitive improvement is warranted. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 57 条
  • [1] Nicotinic mechanisms of memory:: effects of acute local DHβE and MLA infusions in the basolateral amygdala
    Addy, NA
    Nakijama, A
    Levin, ED
    [J]. COGNITIVE BRAIN RESEARCH, 2003, 16 (01): : 51 - 57
  • [2] The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents
    Boess, Frank G.
    De Vry, Jean
    Erb, Christina
    Flessner, Timo
    Hendrix, Martin
    Luithle, Joachim
    Methfessel, Christoph
    Riedl, Bernd
    Schnizler, Katrin
    van der Staay, Franz-Josef
    van Kampen, Marja
    Wiese, Welf Burkhard
    Koenig, Gerhard
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02) : 716 - 725
  • [3] Brown J.A., 2014, NEUROCHEM R IN PRESS, DOI [10.1007/s11064-11014-11302-11066, DOI 10.1007/S11064-11014-11302-11066]
  • [4] Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development
    Buccafusco, Jerry J.
    Beach, J. Warren
    Terry, Alvin V., Jr.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (02) : 364 - 370
  • [5] IMPROVEMENT IN PERFORMANCE OF A DELAYED MATCHING-TO-SAMPLE TASK BY MONKEYS FOLLOWING ABT-418 - A NOVEL CHOLINERGIC CHANNEL ACTIVATOR FOR MEMORY ENHANCEMENT
    BUCCAFUSCO, JJ
    JACKSON, WJ
    TERRY, AV
    MARSH, KC
    DECKER, MW
    ARNERIC, SP
    [J]. PSYCHOPHARMACOLOGY, 1995, 120 (03) : 256 - 266
  • [6] Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
    Caldarone, Barbara J.
    Wang, Daguang
    Paterson, Neil E.
    Manzano, Michael
    Fedolak, Allison
    Cavino, Katie
    Kwan, Mei
    Hanania, Taleen
    Chellappan, Sheela K.
    Kozikowski, Alan P.
    Olivier, Berend
    Picciotto, Marina R.
    Ghavami, Afshin
    [J]. PSYCHOPHARMACOLOGY, 2011, 217 (02) : 199 - 210
  • [7] Nicotinic antagonist effects in the mediodorsal thalamic nucleus: Regional heterogeneity of nicotinic receptor involvement in cognitive function
    Cannady, Reginald
    Weir, Ruth
    Wee, Boyoung
    Gotschlich, Emily
    Kolia, Nadeem
    Lau, Edward
    Brotherton, Jesse
    Levin, Edward D.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2009, 78 (07) : 788 - 794
  • [8] Frontal cortical α7 and α4β2 nicotinic acetylcholine receptors in working and reference memory
    Chan, Wai Kit
    Wong, Peter Tsun-Hon
    Sheu, Fwu-Shan
    [J]. NEUROPHARMACOLOGY, 2007, 52 (08) : 1641 - 1649
  • [9] Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
    Coe, JW
    Brooks, PR
    Vetelino, MG
    Wirtz, MC
    Arnold, EP
    Huang, JH
    Sands, SB
    Davis, TI
    Lebel, LA
    Fox, CB
    Shrikhande, A
    Heym, JH
    Schaeffer, E
    Rollema, H
    Lu, Y
    Mansbach, RS
    Chambers, LK
    Rovetti, CC
    Schulz, DW
    Tingley, FD
    O'Neill, BT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) : 3474 - 3477
  • [10] Dwoskin LP, 2001, J PHARMACOL EXP THER, V298, P395